UNSPSC 51391616: Milrinone lactate

This classification denotes a phosphodiesterase inhibitor with the molecular formula C12H9N3O.C3H6O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9K8XR81MO8, chemically known as 1,6-dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile but more generally known as milrinone lactate, which bears US NIH Compound Identifier 4197. European Medicines Agency schedules Milrinone lactate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14579MIG.

Most nations, for tariff and trade purposes, schedule milrinone lactate under HS 29337900 and SITC 51561. As of Q4 2014, MILRINONE LACTATE remains US FDA's Preferred Term for this commodity. Milrinone lactate bears US NLM identifiers UMLS ID C0699132 and NCI Concept Code C29263. SMILES: CC1C(CC(C(=O)[NH]1)C#N)C2CCNCC2.CC(C(=O)O)O.

UNSPSC 51391616 Milrinone lactate is a Commodity code that nominally covers pharmaceutical preparations, but the recent state and local solicitation activity under this code does not align with the code's stated scope. Seminole County, Florida posted a competitive IFB (IFB60459723LAS) for procurement of naloxone and drug deactivation systems — products outside the milrinone lactate pharmaceutical family — suggesting a tagging or classification mismatch in the procurement record. State and local governments buying under codes in this general pharmaceutical tier typically source injectable pharmaceuticals, intravenous solutions, and specialty medications for hospital systems, county health departments, emergency medical services, and public health programs. The issuing bodies are county health departments, county procurement offices, and municipal public health agencies. The Seminole County solicitation reflects public health demand for opioid-reversal and harm-reduction supplies, a growing category of public-sector procurement, though the specific assignment to the milrinone lactate code appears to be an error rather than a pattern of activity in this commodity line.

Geographic activity is presently limited to a single identified opportunity in Florida. Seminole County's IFB, posted June 30, 2026, with a response deadline of July 26, 2023 (a date discrepancy in the source), seeks annual delivery of 1,900 units of naloxone and 800 safe drug deactivation systems on a quarterly schedule to the Seminole County Community Health Building in Sanford. The contract carries a two-year initial term with a one-year renewal option, fixed-fee pricing, E-Verify compliance, and potential FEMA funding with associated federal regulatory requirements. Given the mismatch between the code definition and the actual procurement, this code shows little relevant recent activity for vendors in the milrinone lactate pharmaceutical supply chain.